Olivares is a world-class IP law firm who represents some of the world’s biggest brands in Mexico. The firm relies on nearly 50 years of experience to offer a full range of IP, regulatory, administrative and some corporate law services, across all industries. Much of Olivares’ strength and uniqueness comes from its sustained efforts to change and improve IP regulation in Mexico. Through its Life Science practice the firm represents many of the world’s leading innovators involved in research, development, and manufacture of pharmaceuticals, biotech products, agricultural goods, chemicals, medical devices, as well as various types of food and beverages.
Contact details
Olivares
Pedro Luis Ogazón 17
Col. San Ángel,
CP 01000, México, D.F.
MEXICO
Tel.: +52 (55) 5322 3000
Website: www.olivares.com.mx
The current negotiations for the Trans-Pacific Partnership (TPP) provide Mexico with a not-to-be-missed opportunity to review the country’s intellectual property system. The partner of the life science practice of the…
Alfa Wassermann is a pharmaceutical group with an Italian heart and an international outlook. The general manager for Mexico discusses the competitive advantages Mexico offered to start operations in Latin…
AstraZeneca’s global strategic objectives are to achieve scientific leadership, to return to growth and to be a great place to work. The newly appointed president of the Mexico subsidiary discusses…
Since he took office in December 2012, President Enrique Peña Nieto has achieved much in terms of the number of major reforms passed in Mexico. Besides the most expected change…
During 2013 Mundipharma entered Brazil, Mexico and Colombia to consolidate its presence in the Latin American region. The general director for Mexico discusses the company’s plans to become leader in…
UCB has transformed into a specialty care pharma which focuses on bringing solutions to patients suffering from severe chronic diseases. The vice president and region head for Americas discusses how…
Mexico is one of GSK’s growth engines in Latin America. The VP and general manager for Mexico discusses how the country is increasingly playing a strategic role for the company…
Aspen Labs wants Latin America to be the third pillar of success for the company, and is doing it in a different way. The CEO for Spanish Latin America discusses…
Indian companies are increasingly interested in tapping into the alluring Mexican and Latin American pharmaceutical markets. The general manager of the API and drug producer discusses the vision behind the…
The executive director and general manager of Amgen Mexico discusses how the company relies on Mexico as a hub for clinical research, with an investment of over USD 22 million…
The executive director and general manager of Amgen Mexico discusses how the company relies on Mexico as a hub for clinical research, with an investment of over USD 22 million…
Recognized by the University of Pennsylvania as one of the top 30 think tanks in the world for health policy, FUNSALUD is committed to propose solutions to Mexico’s most important…
In July 2012 COFEPRIS (the Federal Commission for the Protection against Sanitary Risk) was recognized as a national regulatory authority of regional reference by the PAHO (Pan-American Health Organization), opening…
See our Cookie Privacy Policy Here
